Sourav K. Mishra, M.D. / All India Institute of Medical Sciences
Warning LetterOpen
Recipient Name Sourav K. Mishra, M.D., Sourav K. Mishra, M.D. / All India Institute of Medical Sciences, Sijua, Patrapada Bhubaneswar 751019 Odisha IndiaIssued Apr 29, 2026Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.
Violations4
Issue DateApr 29, 2026
Product TypeDrugs
StatusOpen
Letter Details
Firm
Sourav K. Mishra, M.D. / All India Institute of Medical Sciences
Location
Recipient Name Sourav K. Mishra, M.D., Sourav K. Mishra, M.D. / All India Institute of Medical Sciences, Sijua, Patrapada Bhubaneswar 751019 Odisha India
FEI Number
N/A
Country
India
Issue Date
April 29, 2026
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
In Vivo Bioavailability-Bioequivalence Studies – Clinical
Sourav K. Mishra, M.D. / All India Institute of Medical Sciences FDA Warning Letter, April 29, 2026
Talk to a Specialist